HE homepage

Trending

From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy
Data breach at chain of clinics impacts 450K patients
Amazon One Medical sued after patient prescribed inhaler dies in ER
Merck spends up to $2B to license new weight loss drug with potential heart benefits
Mangione charged with terrorism-related murder in UnitedHealthcare CEO killing
Luigi Mangione Mugshot Pennsylvania
Mangione now faces federal charges, death penalty in murder of UHC CEO

After Luigi Mangione, the man accused of killing UnitedHealthcare CEO Brian Thompson, was extradited to New York, federal prosecutors unsealed a new set of murder charges. 

FDA issues Class I recall on counterfeit infusion pump batteries

ICU Medical alerted customers to knockoff batteries being circulated by suppliers. Due to a risk of the batteries not holding a charge, the recall has been given the FDA’s most serious designation. 

FDA warning alert exclamation computer
FDA issues alert on PCNL sheath safety after patient death

Trokamed sent a letter to customers warning them to never use its Mini PCNL Sheaths for suction and irrigation, due to a risk of kidney rupture. 

RSNA Board member Richard Heller, MD, explains issues with Medicare reinburements and the No Surprises Act and Congressional actions that may fix both.
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Artivion, an Atlanta-based medical device company, has received a Humanitarian Device Exemption (HDE) from the U.S. Food and Drug Administration (FDA) for its AMDS Hybrid Prosthesis designed to treat DeBakey Type 1 dissections when malperfusion occurs. This HDE ensures select patients can be treated with the device before the FDA makes its final approval decision.
First surgical device of its kind granted key FDA exemption

This update helps ensure Artivion's AMDS Hybrid Prosthesis can be used to treat high-risk patients as the FDA makes its final approval decision. The news came as Artivion works to bounce back from a cybersecurity attack that occurred in November.

UnitedHealthcare CEO Shooter NYPD Crime Stoppers
Suspect in murder of UnitedHealthcare CEO arrested in Pennsylvania

Luigi Mangione, 26, was on a Greyhound bus traveling through the area on Monday morning. When he stopped at a McDonald's, an employee recognized him from photos circulated by the NYPD. Mangione had evidence on his person linking him to the crime, police said.

UnitedHealthcare CEO murder suspect NYPD photo 1
Murder of UnitedHealthcare CEO: Everything we know

New photos of the suspect have been released by the New York City Police Department as the manhunt for Brian Thompson's killer enters its second week. 

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.